Yubo International Biotech Ltd (YBGJ) stock
YBGJOTCElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2027, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 5/30
$0.01+0.00 (0.00%)
Close on Oct 16, 2026Market cap $886.19KP/E –Yield –
Yubo International Biotech ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Yubo International Biotech's ebitda for the twelve months ending Jun 30, 2026 was -$1.01M. For fiscal 2026 it was -$1.02M. The highest annual figure on record is -$1.02M in fiscal 2024.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Dec 31, 2025 | -$1.02M | – |
| FY2025 | Dec 31, 2024 | -$1.60M | – |
| FY2024 | Dec 31, 2023 | -$1.02M | – |
| FY2023 | Dec 31, 2022 | -$1.19M | – |
| FY2022 | Dec 31, 2021 | -$1.53M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2027CQ2 2026 | Jun 30, 2026 | -$238.07K | – |
| Q1 FY2027CQ1 2026 | Mar 31, 2026 | -$263.53K | – |
| Q4 FY2026CQ4 2025 | Dec 31, 2025 | -$242.79K | – |
| Q3 FY2026CQ3 2025 | Sep 30, 2025 | -$268.24K | – |
| Q2 FY2026CQ2 2025 | Jun 30, 2025 | -$207.96K | – |
| Q1 FY2026CQ1 2025 | Mar 31, 2025 | -$425.68K | – |
| Q4 FY2025CQ4 2024 | Dec 31, 2024 | -$318.13K | – |
| Q3 FY2025CQ3 2024 | Sep 30, 2024 | -$486.77K | -1061.4% |
| Q2 FY2025CQ2 2024 | Jun 30, 2024 | -$429.03K | – |
| Q1 FY2025CQ1 2024 | Mar 31, 2024 | -$366.12K | – |
| Q4 FY2024CQ4 2023 | Dec 31, 2023 | -$405.32K | -484.4% |
| Q3 FY2024CQ3 2023 | Sep 30, 2023 | $50.63K | – |
| Q2 FY2024CQ2 2023 | Jun 30, 2023 | -$351.76K | – |
| Q1 FY2024CQ1 2023 | Mar 31, 2023 | -$309.94K | – |
| Q4 FY2023CQ4 2022 | Dec 31, 2022 | $105.44K | – |
| Q3 FY2023CQ3 2022 | Sep 30, 2022 | -$235.20K | – |
| Q2 FY2023CQ2 2022 | Jun 30, 2022 | -$488.21K | – |
| Q1 FY2023CQ1 2022 | Mar 31, 2022 | -$573.36K | – |
| Q4 FY2022CQ4 2021 | Dec 31, 2021 | -$390.57K | – |
| Q3 FY2022CQ3 2021 | Sep 30, 2021 | -$342.61K | – |
| Q2 FY2022CQ2 2021 | Jun 30, 2021 | -$366.66K | – |
| Q1 FY2022CQ1 2021 | Mar 31, 2021 | -$433.64K | – |
See a number that looks wrong?